Woodford Investment Management (WIM) is seeking to raise an initial £200m for the launch of the Woodford Patient Capital investment trust, a portfolio of 50-100 quoted and unquoted businesses.
Contrary to speculation that manager Neil Woodford’s second offering at WIM would focus wholly on biotechnology companies, the trust will invest broadly in firms with “outstanding” intellectual property,...
Acquisition completed earlier this month.
Changes to take place by next year
Launched 18 November
Investment Association to create new labels